What Should Hemoglobin A1c Be? Targets by Age

For most adults with diabetes, a hemoglobin A1c below 7% is the general starting target, but the right number for you depends heavily on your age, overall health, and the risks that come with pushing blood sugar lower. Children, healthy middle-aged adults, and older adults with multiple chronic conditions can all have different goals, sometimes separated by more than a full percentage point. The reason targets shift across the lifespan has less to do with age itself and more to do with how the balance between benefit and harm changes as the body ages and accumulates other health problems.

How A1c Reflects Blood Sugar Over Time

Hemoglobin A1c forms when glucose in your blood attaches to hemoglobin, the protein inside red blood cells that carries oxygen. This happens slowly and continuously throughout the roughly 120-day life of each red blood cell. Because the process is cumulative, A1c gives a weighted average of your blood sugar over the prior two to three months, with the most recent 30 days contributing more heavily than the period 90 to 120 days earlier.¹ That time-averaging is what makes A1c useful for tracking long-term blood sugar control rather than the moment-to-moment swings a fingerstick glucose reading captures.

The Standard Adult Target and Where It Came From

The American Diabetes Association has long recommended an A1c below 7% for most nonpregnant adults with diabetes. That threshold is rooted in large trials showing that keeping A1c under 7% substantially reduces the risk of damage to small blood vessels in the eyes, kidneys, and nerves. The American College of Physicians, however, recommends a slightly more relaxed range of 7% to 8% for most adults with type 2 diabetes, reasoning that the added effort and medication burden of pushing below 7% does not always produce enough additional benefit to justify the risks.² The American Association of Clinical Endocrinologists has at times pushed for a tighter goal of 6.5% or lower, as long as it can be achieved safely.³ These disagreements among professional societies reflect genuine uncertainty about where the sweet spot lies, and they underscore why the current trend in guidelines has moved away from one-size-fits-all numbers toward personalized targets.⁴

If you are a younger or middle-aged adult with type 2 diabetes, relatively few other health problems, and a long life expectancy ahead of you, a tighter A1c target makes intuitive sense. Years of even modestly elevated blood sugar compound into microvascular complications like kidney disease, retinopathy, and nerve damage, and poor control combined with a long duration of diabetes accelerates that timeline.⁵ For this group, aiming for an A1c below 7%, or even close to 6.5% when it can be done without frequent low blood sugar episodes, is generally well supported.

Targets for Children and Adolescents

Pediatric A1c targets have shifted meaningfully over the past decade. The American Diabetes Association now recommends below 7% for many children with type 1 diabetes, with an emphasis on tailoring the target to the individual child. A slightly higher goal of below 7.5% may fit better for younger children who cannot recognize or articulate symptoms of low blood sugar, or for families without access to insulin pumps and continuous glucose monitors. For children with a history of severe hypoglycemia or serious coexisting illnesses, an even more relaxed target of below 8% can be appropriate. And during the “honeymoon” period early in a type 1 diabetes diagnosis, when the pancreas still produces some insulin, an A1c below 6.5% may be safe and achievable without excessive low blood sugar.⁶

The general direction in pediatric diabetes care has been toward tighter control than what was recommended a generation ago, driven partly by improved technology and partly by accumulating evidence that complications can begin during adolescence if blood sugar stays high. But the personalization piece matters enormously. A teenager managing diabetes alone with limited resources is in a very different situation from a child whose family has access to the latest insulin pump and a dedicated care team.

Why Targets Loosen for Older Adults

The evidence is consistent across multiple guidelines: older adults in good health can aim for an A1c around 7% to 7.5%, while those who are frail, have multiple chronic conditions, or live with cognitive impairment are generally better served by a more relaxed target of 8% to 8.5%.⁷ A systematic review of 15 clinical practice guidelines found broad agreement on this two-tier approach.⁸ The reasoning comes down to risk and time horizon.

The benefits of tight blood sugar control take years to fully materialize. Someone who keeps their A1c at 7% instead of 8% reduces their chance of developing kidney disease or vision loss over the next 10 to 15 years. But that time-to-benefit calculation changes dramatically for someone who is 82 years old, lives in a nursing home, or has advanced kidney disease or heart failure. The American College of Physicians is blunt about this, recommending against targeting any specific A1c number for people with a life expectancy under 10 years, because the harms of intensive treatment outweigh the benefits in that group.² The goal shifts from preventing long-term complications to keeping blood sugar controlled enough to avoid symptoms of high blood sugar like excessive thirst, frequent urination, and fatigue.

The Real Danger of Pushing Too Low in Older Adults

The main harm of aggressive A1c lowering in older people is hypoglycemia, and the consequences go well beyond feeling shaky and sweaty. Low blood sugar in the elderly is a direct pathway to falls, and falls in this population are a leading cause of serious injury and death. In one cross-sectional study of older adults with diabetes, those who experienced hypoglycemic symptoms were roughly two and a half times more likely to fall and six times more likely to have recurrent falls.⁹ A separate analysis confirmed that hypoglycemia is independently associated with fall risk in older adults with type 2 diabetes, even after accounting for other risk factors like polypharmacy and arthritis.¹⁰

Mortality data add another layer of concern. Retrospective studies have found a U-shaped relationship between A1c and death, meaning that both very high and very low A1c levels are associated with increased mortality in older adults. The risk of dying was elevated both above about 9% and below about 7%.¹¹ That U-shape is a warning sign that chasing a low number with intensive medication therapy can be actively dangerous for some patients, not just unhelpful.

There is also evidence connecting overly tight glucose control in older adults with diabetes to cognitive decline. One study found a significant association between A1c levels at or below 6% and severe cognitive impairment in diabetic patients, a link that did not appear in nondiabetic individuals.¹² Another study found that older adults with type 2 diabetes whose A1c dropped quickly from above 7.5% to below 7.5% within a year had nearly double the odds of developing dementia compared with those whose A1c remained more stable.¹³ Whether hypoglycemia itself drives the cognitive decline or there is some other mechanism at work is not entirely settled, but the pattern is concerning enough that clinicians are urged to take rapid, large drops in A1c seriously as a potential red flag.

Scaling Back Medications When A1c Is Too Low

Despite the evidence that older adults on aggressive diabetes regimens are being put at unnecessary risk, de-intensification, the process of reducing or stopping diabetes medications, happens less often than it should. A large proportion of older adults treated with medications that can cause low blood sugar have A1c levels well below the recommended lower bounds for their age and health status, suggesting they are being overtreated.¹⁴

Part of the problem is inertia. A randomized trial found that a structured decision-support tool combined with patient engagement before doctor visits roughly doubled the rate of medication reduction at six months compared with the tool alone. Even with both interventions, though, only about a quarter of eligible patients had their medications reduced within a year.¹⁵ Patient attitudes play a role too. In a large cohort of adults aged 65 and older, those who did not expect to need diabetes medication for life were about 50% more likely to have their medications reduced. Those who did not realize that taking fewer pills could raise blood sugar were also more likely to undergo deprescribing, which suggests that informed conversations between patients and doctors can go either way and underscores the importance of shared decision-making.¹⁶

If you are an older adult on insulin or sulfonylureas and your A1c has been running below 6.5%, it is worth asking your doctor whether your regimen should be dialed back. The American College of Physicians explicitly recommends considering de-intensification in that scenario.²

When A1c Does Not Tell the Full Story

A1c is a blood-sugar average, and averages can hide important details. Two people with the same A1c of 7.5% might have very different day-to-day blood sugar patterns: one could run steadily around 160 mg/dL, while the other swings between 60 and 300. A1c cannot distinguish between the two, even though the second person is experiencing dangerous lows and highs that the first is not.

Red blood cell lifespan is one factor that can throw off A1c readings. Because A1c accumulates over the life of each red blood cell, anything that shortens or lengthens that lifespan changes the reading independent of actual blood sugar. Modeling work has shown that a person with a shorter red cell lifespan of about 80 days could show an A1c reading roughly 2 percentage points lower than what their true glucose exposure would predict, potentially masking poor control. Conversely, someone with a longer red cell lifespan of about 130 days might show a falsely elevated A1c, leading to unnecessary treatment escalation.¹⁷ A study in people with type 2 diabetes confirmed a significant inverse relationship between red blood cell lifespan and A1c: shorter-lived red cells correlated with lower A1c values relative to actual glucose control.¹⁸

Severe anemia and advanced kidney disease can also affect the accuracy of A1c. In a large primary-care database analysis, mild to moderate anemia and mild to moderate kidney disease did not meaningfully distort the relationship between fasting glucose and A1c. The correlation broke down only at the severe end, where severe anemia caused A1c to underestimate blood sugar and advanced kidney disease (with an estimated filtering rate below 45) caused A1c to overestimate it.¹⁹ For most people these conditions do not make A1c useless, but for those at the severe end of the spectrum, the number on the lab report may not mean what it normally means.

Racial and Ethnic Differences in A1c

One of the more uncomfortable realities of A1c testing is that the same blood sugar level does not always produce the same A1c reading across racial groups. Two studies using different datasets found that Black individuals consistently had higher A1c values than white individuals even after adjusting for measured glucose levels and other relevant factors. The gap was about 0.4 percentage points at a given average glucose concentration in one study,²⁰ and ranged from about 0.13 to 0.47 percentage points across normal, prediabetic, and diabetic glucose ranges in the other.²¹ The causes are not fully understood and likely involve biological differences in hemoglobin glycation rates rather than differences in actual glucose exposure.

This matters for diagnosis and treatment. Using a fixed A1c cutoff of 6.5% to diagnose diabetes has low sensitivity overall, missing about three-quarters of diabetes cases identified by glucose-based testing.²² For Black patients, the implication is that an A1c of, say, 7.2% may correspond to a lower average glucose than the same reading in a white patient. This does not mean A1c is useless for Black individuals, but it does mean that treatment decisions made solely on A1c without considering glucose data could lead to overtreatment in some cases.

Continuous Glucose Monitors and Time in Range

Continuous glucose monitors have introduced a metric called “time in range,” typically defined as the percentage of the day spent with glucose between 70 and 180 mg/dL. In young people with type 1 diabetes, time in range correlates strongly with A1c, which is reassuring.²³ But the real value of time in range is the information A1c cannot provide: how much time you spend dangerously low, how much time you spend excessively high, and how stable your glucose is throughout the day. For an older adult whose A1c target has been relaxed to 8%, time in range and time below range can be far more useful for day-to-day medication decisions than waiting three months for a new A1c result.

Alternative Blood Tests When A1c Is Unreliable

For people whose A1c cannot be trusted because of hemoglobin variants, severe anemia, heavy blood loss, recent transfusions, or advanced kidney disease, alternative markers exist. Fructosamine and glycated albumin both reflect shorter windows of glucose control, roughly two to three weeks, and are not affected by red blood cell turnover.²⁴ These markers also capture postmeal glucose spikes better than A1c does, making them useful supplements even when A1c is reliable.²⁵ Data from a large community-based cohort suggest that fructosamine and glycated albumin provide prognostic information about diabetes risk and microvascular complications that complements rather than replaces A1c.²⁶ They are not yet standard in routine diabetes management, but your doctor may order them if your A1c results seem inconsistent with your glucose readings.

A1c During Pregnancy

Pregnancy adds its own urgency. Blood sugar targets during pregnancy are considerably tighter than the usual adult goals because even modest elevations in maternal glucose can affect fetal development. A1c can drop quickly in pregnant women receiving treatment: in a small study of women with gestational diabetes who started with an average A1c near 8.8%, the value dropped by roughly half a percentage point per week with intensive monitoring.²⁷ That pace of change is far faster than what is typical outside pregnancy and illustrates why A1c monitoring can be done at shorter intervals during gestation. Most guidelines recommend keeping A1c below 6% to 6.5% in pregnancy when it can be done safely, though the specifics depend on the type of diabetes and how far along the pregnancy is.

The broader point is that pregnancy is one of the few situations where the usual caution about pushing A1c lower is flipped. The time horizon for benefit is measured in weeks and months, not years, and the stakes involve a developing fetus. For pregnant women with preexisting diabetes, tighter control before conception and during the first trimester is especially important.